We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

A LoGiCal® Success at Analytical Services International

Read time: Less than a minute

Analytical Services International (ASI) at St George’s, University of London, UK, has been evaluating LoGiCal certified reference materials - a new product range from LGC Standards - for its therapeutic drug monitoring (TDM) services, where high quality reference standards are an essential requirement.

The use of high quality reference materials is equally important for the Company’s international proficiency testing scheme for immunosuppressive drugs, co-ordinated by Professor David Holt.

ASI recently validated the use of LoGiCal solutions of the immunosuppressant mycophenolic acid (MPA) and antiarrhythmic amiodarone metabolite desethylamiodarone (DEA) in its assays.

Michelle Moreton-Clack, TDM Service Manager, explained: “As part of our therapeutic drug monitoring service, we run assays for the measurement of MPA and DEA. We usually buy the drugs in powder form and weigh them out to prepare stock solutions for our assays. The LoGiCal range includes ISO Guide 34 certified solutions of MPA and DEA, which are really easy to use and save a lot of time by eliminating weighing stages. We validated both compounds against our existing stock solutions, and they showed good correlation; I am very pleased with the results.”